|Bid||0.00 x 0|
|Ask||125.00 x 100|
|Day's range||109.40 - 115.54|
|52-week range||94.00 - 128.46|
|PE ratio (TTM)||11.76|
|Earnings date||7 Feb 2018 - 12 Feb 2018|
|Forward dividend & yield||N/A (N/A)|
|1y target est||100.00|
The Haifa Bay, Israel-based company said it had profit of $1.30 per share. The drug maker posted revenue of $169.9 million in the period. Taro shares have climbed almost 5 percent since the beginning of ...
November 7, 2017-- Taro Pharmaceutical Industries Ltd. today provided unaudited financial results for the three and six months ended September 30, 2017.
Taro Pharmaceutical Industries Ltd. announced today that it plans to release its financial results for the quarter and six months ended September 30, 2017, on Tuesday, November 7, 2017.